Akari Therapeutics (AKTX) news

PLC Resources Ltd - Geo-spectral survey commences at Abbotts Gold project, WA

PLC Resources Ltd (ASX: PLC) has announced the commencement of a geo-spectral survey at its Abbotts Gold project in Western Australia. The survey is part of the company’s ongoing exploration efforts to identify potential gold-bearing structures within the project area. Geo-spectral surveys utilise…

Akari Therapeutics appoints accomplished oncology and ADC deal executive Vatak Vat-Ho as chief business officer to drive strategic growth and partnering

Akari Therapeutics expands intellectual property portfolio with PCT filing for ADC payload related to RNA splicing in cancers

Akari Therapeutics has expanded its intellectual property portfolio by filing a Patent Cooperation Treaty (PCT) application for an antibody-drug conjugate (ADC) payload related to RNA splicing in cancers. This development follows recent patent grants in Europe and Australia for ADC technologies,…

Akari Therapeutics enters strategic research collaboration with Whitehawk Therapeutics

Akari Therapeutics PLC: Maxim Group raises to buy from hold

Maxim Group has upgraded its rating for Akari Therapeutics PLC (AKTX), moving from "Hold" to "Buy," reflecting a positive shift in the firm's outlook for the biopharmaceutical company. The decision follows recent developments in Akari's clinical pipeline and strategic initiatives aimed at advancing…